6-(4-methyl-1-piperazinyl)morphanthridine,
6-(4-methylpiperazin-1-yl)-11H-dibenzazepine,
HUF-2333,
perlapine,
perlapine monohydrochloride,
PLP 100-127,
PERLAPINE,
Hypnodin,
1977-11-3,
Perlapin,
Perlapina [Spanish],
6-(4-Methyl-1-piperazinyl)morphanthridine,
AW-14'2333,
Perlapinum [INN-Latin],
Morphanthridine, 6-(4-methyl-1-piperazinyl)-,
Perlapina [INN-Spanish],
UNII-4N8UJJ27IM,
4N8UJJ27IM,
CHEMBL340801,
AW 14'2333,
Perlapine [USAN:INN:BAN:JAN],
MP-11,
NSC291840,
NSC 291840,
HF-2333,
BRN 0434631,
6-(4-methylpiperazin-1-yl)-11H-benzo[c][1]benzazepine,
6-(4-Methyl-1-piperazinyl)morfantridin,
NCGC00182979-01,
6-(4-Methyl-1-piperazinyl)-11H-dibenz(b,e)azepine,
11H-Dibenz(b,e)azepine, 6-(4-methyl-1-piperazinyl)-,
C19H21N3,
6-(4-methyl-1-piperazinyl)-11h-dibenz[b,e]azepine,
11H-Dibenz[b,e]azepine, 6-(4-methyl-1-piperazinyl)-,
Perlapinum,
Perlapina,
Hypnodin (TN),
AC1Q3ZWQ,
DSSTox_CID_28684,
DSSTox_RID_82954,
DSSTox_GSID_48758,
Perlapine (JAN/USAN/INN),
SCHEMBL114768,
AC1L279X,
DTXSID1048758,
CHEBI:31983,
PWRPUAKXMQAFCJ-UHFFFAOYSA-N,
Tox21_113222,
BDBM50102325,
PDSP1_000475,
PDSP2_000473,
ZINC27303430,
AKOS027470205,
API0003796,
NSC-291840,
LS-60495,
CAS-1977-11-3,
AW-142333,
11H-Dibenz[b, 6-(4-methyl-1-piperazinyl)-,
D01438,
WLN: T C676 IN BHJ J- AT6N DNTJ D1,
L001286,
6-(4-Methyl-1-piperazinyl)-11H-dibenzo[b,e]azepine,
Morphanthridine, 6-(4-methyl-1-piperazinyl)- (8CI),
6-(4-Methyl-piperazin-1-yl)-11H-dibenzo[b,e]azepine,
{11H-Dibenz[b,e]azepine,} 6-(4-methyl-1-piperazinyl)-,
perlapine HCl,
perlapine hydrochloride,
perlapine monohydrochloride,
CID16106,
HUF-2333,
5-23-03-00089 (Beilstein Handbook Reference),
PLP,